Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Members' Deficit/Shareholders' Equity

v3.21.2
Condensed Statements of Changes of Members' Deficit/Shareholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Members Interests
Nonvoting Common Stock
Members Interests
Voting Common Stock
Accumulated Deficit
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         $ (466,553) $ (466,553)
Beginning Balance at Dec. 31, 2019     $ 12,601,201   (17,618,710) (5,017,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         (466,553) (466,553)
Ending Balance at Mar. 31, 2020     12,601,201   (18,085,263) (5,484,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (3,845,167)
Beginning Balance at Dec. 31, 2019     12,601,201   (17,618,710) (5,017,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (3,845,167)
Ending Balance at Sep. 30, 2020       $ 16,239,001 (21,463,877) (5,224,876)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         (654,585) (654,585)
Beginning Balance at Mar. 31, 2020     12,601,201   (18,085,263) (5,484,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Membership conversion to voting interests     $ (12,601,201) 12,601,201    
Net loss         (654,585) (654,585)
Ending Balance at Jun. 30, 2020       12,601,201 (18,739,848) (6,138,647)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         (2,724,029) (2,724,029)
Conversion of convertible promissory notes       1,637,800   1,637,800
Equity-based compensation expense       2,000,000   2,000,000
Net loss         (2,724,029) (2,724,029)
Ending Balance at Sep. 30, 2020       $ 16,239,001 (21,463,877) (5,224,876)
Balances, Beginning at Dec. 31, 2020 $ 830 $ 57,905,164     (27,965,105) 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense   24,825       24,825
Exercise of warrants $ 3 197,559       197,562
Exercise of warrants (in shares) 25,315          
Net loss         (3,056,033) (3,056,033)
Balances, Ending at Mar. 31, 2021 $ 833 58,127,548     (31,021,138) 27,107,243
Balances, Ending (in shares) at Mar. 31, 2021 8,330,390          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         (3,056,033) (3,056,033)
Balances, Beginning at Dec. 31, 2020 $ 830 57,905,164     (27,965,105) 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (11,448,977)
Balances, Ending at Sep. 30, 2021 $ 833 58,293,698     (39,414,082) 18,880,449
Balances, Ending (in shares) at Sep. 30, 2021 8,330,390          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (11,448,977)
Balances, Beginning at Mar. 31, 2021 $ 833 58,127,548     (31,021,138) 27,107,243
Balances, Beginning (in shares) at Mar. 31, 2021 8,330,390          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense   34,244       34,244
Net loss         (4,282,962) (4,282,962)
Balances, Ending at Jun. 30, 2021 $ 833 58,161,792     (35,304,100) 22,858,525
Balances, Ending (in shares) at Jun. 30, 2021 8,330,390          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         (4,282,962) (4,282,962)
Share-based compensation expense   131,906       131,906
Net loss         (4,109,982) (4,109,982)
Balances, Ending at Sep. 30, 2021 $ 833 $ 58,293,698     (39,414,082) 18,880,449
Balances, Ending (in shares) at Sep. 30, 2021 8,330,390          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss         $ (4,109,982) $ (4,109,982)